These are the 22 small cap biotechs closest to bringing a drug to market

There are no shortage of small cap health and biotech companies listed on the ASX — around 140 or so — but less than 25 are anywhere close to their ultimate dream of bringing a drug successfully to market, a Stockhead analysis has found. Taking a drug or treatment from an idea to the lab, […]